From: β-lactam antibiotic concentrations during continuous renal replacement therapy
Patients (n = 50) | |
---|---|
Age, years | 59 (51 to 67) |
Men/women, n | 33/17 |
Body weight, kg | 75 (68 to 85) |
Body mass index, kg/m2 | 26.3 (23.9 to 27.9) |
COPD/asthma, n (%) | 8 (16) |
Cardiopathy, n (%) | 19 (38) |
Diabetes mellitus, n (%) | 17 (34) |
sCr >2 mg/dL, n (%) | 13 (26) |
Liver cirrhosis, n (%) | 18 (36) |
Cancer, n (%) | 7 (14) |
Immunosuppressive agents, n (%) | 20 (40) |
Organ transplantation, n (%) | 17 (30) |
Medical admission, n (%) | 39 (78) |
APACHE II score on admission | 21 (17 to 25) |
Lactate levels on admission, mEq/L | 2.6 (1.5 to 3.9) |
Mechanical ventilation during ICU stay, n (%) | 36 (72) |
ICU stay, days | 15 (10 to 21) |
Hospital stay, days | 23 (15 to 53) |
ICU mortality, n (%) | 25 (50) |
Hospital mortality, n (%) | 30 (60) |